โ
??โ:ํ
๋ โmak856 ??โ:์นดํกโ123w
โ๋ผ์ธใkom85ใ
??โ:ํ
๋ โmak856 ??โ:์นดํกโ123w
โ๋ผ์ธใkom85ใ
Background to drug precursor control
The control of drug precursors is governed by Regulations of the European Parliament and the Council regarding the handling of drug precursors. These Regulations on intra- and extra-Community trade in drug precursors and their implementing Regulation are also given effect under the Finnish Narcotics Act. The Regulations are based on the 1988 Convention against Illicit Trafficking in Drugs and Psychotropic Substances to which the EU is a party.
Drug precursors are scheduled substances referred to in the above-mentioned Regulations that are commonly used in illicit manufacture of drugs. Some of these substances also have legitimate uses as medicinal products. The control and licence procedures applied to drug precursors are not, however, targeted at medicinal products falling under the Directive of the European Parliament and the Council on the Community code relating to medicinal products for human use.
Fimea acts as the Finnish competent authority referred to in the Regulations on intra- and extra-Community trade in drug precursors and their implementing Regulation. Fimea also grants licences to import, export and handle drug precursors and makes decisions regarding operator notifications.
๋ง์ฝ์ฑ์งํต์ #์คํผ์ค์ด๋๊ตฌ์
, #๋ชจ๋ฅดํ๊ตฌ์
,#์คํผ์ค์ด๋๊ตฌ์
,#์ฅ์์ฝ๋๊ตฌ์
,#ํ์ด๋๋ก์ฝ๋๊ตฌ์
,#ํ์ด๋๋ก๋ชฐํฐ๊ตฌ์
,#ํธ๋ผ๋ง๋๊ตฌ์
,#๋ฉํ๋๊ตฌ์
,#ํํ๋๊ตฌ์
,,#์์ด์์ฝ๋๊ตฌ์
#์คํผ์ค์ด๋ํ๋งค, #๋ชจ๋ฅดํํ๋งค,#์คํผ์ค์ด๋ํ๋งค,#์ฅ์์ฝ๋ํ๋งค,#ํ์ด๋๋ก์ฝ๋ํ๋งค,#ํ์ด๋๋ก๋ชฐํฐํ๋งค,#ํธ๋ผ๋ง๋ํ๋งค,#๋ฉํ๋ํ๋งค,#ํํ๋ํ๋งค,#์์ด์์ฝ๋ํ๋งค
โ
โ